What is Ginkgo Bioworks's capex?

Ginkgo Bioworks (DNA) reported capex of $1.93M in Q1 2026.

How has Ginkgo Bioworks's capex changed year-over-year?

Ginkgo Bioworks's capex decreased by 74.6% year-over-year, from $7.62M to $1.93M.

What is the long-term trend for Ginkgo Bioworks's capex?

Over 4 years (2021 to 2025), Ginkgo Bioworks's capex has grown at a -39.3% compound annual growth rate (CAGR), from $56.52M to $7.67M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ginkgo Bioworks DNA CapEx

CapEx at other companies

Thermo Fisher ScientificTMO

$376M+3.9%

Charles River LaboratoriesCRL

$55.91M-5.8%

AbCellera Biologics Inc.ABCL

$3.83M-64.0%

TEC

Bio-TechneTECH

$9.09M-10.2%

AzentaAZTA

$7.4M-0.1%

RegenxbioRGNX

$1.24M+20.6%

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's capex?: Ginkgo Bioworks (DNA) reported capex of $1.93M in Q1 2026.
How has Ginkgo Bioworks's capex changed year-over-year?: Ginkgo Bioworks's capex decreased by 74.6% year-over-year, from $7.62M to $1.93M.
What is the long-term trend for Ginkgo Bioworks's capex?: Over 4 years (2021 to 2025), Ginkgo Bioworks's capex has grown at a -39.3% compound annual growth rate (CAGR), from $56.52M to $7.67M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.